Atenolol is a second-generation beta-1-selective adrenergic antagonist indicated in the treatment of hypertension,Â angina pectoris, and acute myocardial infarction. Non-FDA-approved indications include treatment of arrhythmias, migraine prophylaxis, paroxysmal supraventricular tachycardia, alcohol withdrawal, thyrotoxicosis, and prophylaxis against secondary myocardial infarction.